As required by the FDA, every batch of our infant formula is tested for Salmonella and Cronobacter sakazakii, two pathogens of particular concern in powdered infant formula
[1], [2], [3], [4] A 2021 retrospective study conducted at the Institute for Hormonal Balance in Orlando, Florida, that evaluated the use of BPC 157, alone or in combination with thymosin-beta-4 (TB4), indicates in its methodology that no human clinical trials evaluating the use of BPC 157 to help with knee pain have been published (see Table 1)
We believe that science + consistency = results
Subjects who achieved their target weight then stepped down the dosage for maintenance
Thus, the need for a therapy that can alleviate the social and economic burden that presents itself with debilitating and recurring soft tissue injuries is apparent